CGEM vs OKE · $830.3M cap vs P/E 15, rev $21.70B
Cullinan Oncology LLC (CGEM) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
CGEM currently screens at market cap $830.3M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the CGEM and OKE stock pages for the full models.
Not investment advice.